Rezolute (RZLT) Net Cash Flow (2010 - 2026)
Rezolute recorded quarterly Net Cash Flow of -$662000.0 in Q1 2026, down 123.64% quarter-over-quarter from $2.8 million in Q4 2025, and down 111.69% year-over-year from $5.7 million in Q1 2025.
Rezolute's Net Cash Flow history runs 17 years deep, the most recent figure standing at -$662000.0 for Q1 2026.
- In Q1 2026, Net Cash Flow fell 111.69% year-over-year to -$662000.0; the TTM figure through Mar 2026 stood at -$3.4 million (down 139.06% YoY), while the FY2025 annual figure was $23.7 million, down 56.43% from the prior year.
- Net Cash Flow came in at -$662000.0 for Q1 2026 at Rezolute, down from $2.8 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $82.0 million in Q2 2022 to a low of -$113.0 million in Q1 2023.
- A 5-year average of -$4.2 million and a median of -$1.5 million in 2024 frame the typical range for Net Cash Flow.
- Across the five-year window, Net Cash Flow soared 805.21% in 2022 and sank 707.91% in 2023, its largest moves.
- Rezolute's Net Cash Flow stood at -$7.6 million in 2022, then surged by 162.57% to $4.7 million in 2023, then plunged by 132.49% to -$1.5 million in 2024, then jumped by 281.82% to $2.8 million in 2025, then plunged by 123.64% to -$662000.0 in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$662000.0, $2.8 million, and -$85.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -152.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 60.68 Mn |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - | -662,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -662,000.00 |
| Mar 31, 2026 | -662,000.00 |
| Dec 31, 2025 | 2.80 Mn |
| Dec 31, 2025 | 2.80 Mn |
| Sep 30, 2025 | -85.01 Mn |
| Sep 30, 2025 | -85.01 Mn |
| Jun 30, 2025 | 79.49 Mn |
| Jun 30, 2025 | 79.49 Mn |
| Mar 31, 2025 | 5.66 Mn |
| Mar 31, 2025 | 5.66 Mn |
| Dec 31, 2024 | -1.54 Mn |
| Dec 31, 2024 | -1.54 Mn |
| Sep 30, 2024 | -59.92 Mn |
| Sep 30, 2024 | -59.92 Mn |
| Jun 30, 2024 | 64.47 Mn |
| Jun 30, 2024 | 64.47 Mn |
| Mar 31, 2024 | -6.57 Mn |
| Mar 31, 2024 | -6.57 Mn |
| Dec 31, 2023 | 4.74 Mn |
| Dec 31, 2023 | 4.74 Mn |
| Sep 30, 2023 | -7.98 Mn |
| Sep 30, 2023 | -7.98 Mn |
| Jun 30, 2023 | -17.71 Mn |
| Jun 30, 2023 | -17.71 Mn |
| Mar 31, 2023 | -113.00 Mn |
| Mar 31, 2023 | -113.00 Mn |
| Dec 31, 2022 | -7.58 Mn |
| Dec 31, 2022 | -7.58 Mn |
| Sep 30, 2022 | 3.91 Mn |
| Sep 30, 2022 | 3.91 Mn |
| Jun 30, 2022 | 81.99 Mn |
| Jun 30, 2022 | 81.99 Mn |
| Mar 31, 2022 | -13.99 Mn |
| Mar 31, 2022 | -13.99 Mn |
| Dec 31, 2021 | 45.11 Mn |
| Dec 31, 2021 | 45.11 Mn |
| Sep 30, 2021 | -3.76 Mn |
| Sep 30, 2021 | -3.76 Mn |
| Jun 30, 2021 | 9.06 Mn |
| Jun 30, 2021 | 9.06 Mn |
| Mar 31, 2021 | -5.61 Mn |
| Mar 31, 2021 | -5.61 Mn |
| Dec 31, 2020 | 31.20 Mn |
| Dec 31, 2020 | 31.20 Mn |
| Sep 30, 2020 | -3.55 Mn |
| Sep 30, 2020 | -3.55 Mn |
| Jun 30, 2020 | -4.08 Mn |
| Jun 30, 2020 | -4.08 Mn |
| Mar 31, 2020 | -5.68 Mn |
| Mar 31, 2020 | -5.68 Mn |
| Dec 31, 2019 | -5.50 Mn |
| Dec 31, 2019 | -5.50 Mn |
| Sep 30, 2019 | 13.64 Mn |
| Sep 30, 2019 | 13.64 Mn |
| Jun 30, 2019 | -3.77 Mn |
| Jun 30, 2019 | -3.77 Mn |
| Mar 31, 2019 | 15.09 Mn |
| Mar 31, 2019 | 15.09 Mn |
| Dec 31, 2018 | -143,000.00 |
| Dec 31, 2018 | -143,000.00 |
| Sep 30, 2018 | -1.24 Mn |
| Sep 30, 2018 | -1.24 Mn |
| Jun 30, 2018 | 1.57 Mn |
| Jun 30, 2018 | 1.57 Mn |
| Mar 31, 2018 | -789,952.00 |
| Mar 31, 2018 | -789,952.00 |
| Dec 31, 2017 | -3.15 Mn |
| Dec 31, 2017 | -3.15 Mn |
| Sep 30, 2017 | -470,823.00 |
| Sep 30, 2017 | -470,823.00 |
| Jun 30, 2017 | 49,975.00 |
| Jun 30, 2017 | 49,975.00 |
| Mar 31, 2017 | 863,415.00 |
| Mar 31, 2017 | 863,415.00 |
| Dec 31, 2016 | 207,408.00 |
| Dec 31, 2016 | 207,408.00 |
| Sep 30, 2016 | -696,273.00 |
| Sep 30, 2016 | -696,273.00 |
| Jun 30, 2016 | 2.32 Mn |
| Jun 30, 2016 | 2.32 Mn |
| Mar 31, 2016 | 37,533.00 |
| Mar 31, 2016 | 37,533.00 |
| Dec 31, 2015 | -644,543.00 |
| Dec 31, 2015 | -644,543.00 |
| Sep 30, 2015 | -2.93 Mn |
| Sep 30, 2015 | -2.93 Mn |
| Jun 30, 2015 | -2.95 Mn |
| Jun 30, 2015 | -2.95 Mn |
| Mar 31, 2015 | -365,225.00 |
| Mar 31, 2015 | -365,225.00 |
| Dec 31, 2014 | 4.29 Mn |
| Dec 31, 2014 | 4.29 Mn |
| Sep 30, 2014 | -1.64 Mn |
| Sep 30, 2014 | -1.64 Mn |
| Jun 30, 2014 | 292,907.00 |
| Jun 30, 2014 | 292,907.00 |
| Mar 31, 2014 | 4.50 Mn |
| Mar 31, 2014 | 4.50 Mn |
| Dec 31, 2013 | 1.14 Mn |
| Dec 31, 2013 | 1.14 Mn |
| Sep 30, 2013 | 217.00 |
| Sep 30, 2013 | 217.00 |
| Jun 30, 2013 | -393,583.00 |
| Jun 30, 2013 | -393,583.00 |
| Mar 31, 2013 | 65,807.00 |
| Mar 31, 2013 | 65,807.00 |
| Dec 31, 2012 | 36,619.00 |
| Dec 31, 2012 | 36,619.00 |
| Sep 30, 2012 | 265,806.00 |
| Sep 30, 2012 | 265,806.00 |
| Jun 30, 2012 | 25,232.00 |
| Jun 30, 2012 | 25,232.00 |
| Mar 31, 2012 | 55,893.00 |
| Mar 31, 2012 | 55,893.00 |
| Dec 31, 2011 | 714,516.00 |
| Dec 31, 2011 | 714,516.00 |
| Sep 30, 2011 | 28,248.00 |
| Sep 30, 2011 | 28,248.00 |
| Mar 31, 2011 | 5.00 |
| Mar 31, 2011 | 5.00 |
| Dec 31, 2010 | 26,101.00 |
| Dec 31, 2010 | 26,101.00 |
| Sep 30, 2010 | 3,000.00 |
| Sep 30, 2010 | 3,000.00 |